Patent application number | Description | Published |
20100173955 | 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES - Compounds of Formula (I): in which R | 07-08-2010 |
20110105463 | 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES - Compounds of Formula (I): in which A | 05-05-2011 |
20120065195 | COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES - The invention provides novel spirotetrahydronaphthalene compounds of Formula α that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases. | 03-15-2012 |
20120101103 | 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES - Compounds of Formula I: (I) in which A, A | 04-26-2012 |
20120157448 | COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES - The invention provides novel tricyclic compounds of Formula I′ that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases. | 06-21-2012 |
20140005418 | 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES | 01-02-2014 |
20140221342 | 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES - Provided herein is a method of treating an allergic inflammatory disease selected from asthma, dermatitis, allergic rhinitis, urticaria, anaphylaxis, angioedemea, allergies, contact hypersensitivity, drug hypersensitivity, and allergic conjunctivitis in a mammal, comprising administering a therapeutically effective amount of a compound of Formula I | 08-07-2014 |
20150232442 | 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES - Provided herein are compounds of Formula I: | 08-20-2015 |